<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="13/11/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9164841" creator="Yo Shidahara">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>9164841</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Involvement of the <term sem="Protein_domain_or_region" id="A4"><term sem="Protein_domain_or_region" id="T1" lex="N-terminal_region">N-terminal region</term> of the <term sem="Protein_domain_or_region" id="T2" lex="human_mineralocorticoid_receptor_hormone-binding_domain">human <term sem="Protein_family_or_group" id="A3">mineralocorticoid receptor</term> hormone-binding domain</term></term> in <term sem="Organic_compound_other" id="A1">agonist</term> and <term sem="Organic_compound_other" id="A2">antagonist</term> binding as revealed by a <term sem="Protein_family_or_group" id="T3" lex="new_monoclonal_antibody">new monoclonal antibody</term>.</sentence>
<event id="E1">
<type class="Binding" />
<theme idref="A1" />
<theme idref="A3" />
<clue>Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist <clueType>binding</clueType> as revealed by a new monoclonal antibody.</clue>
<comment>NO COREFETHEME FOR A3</comment>
</event>
<event id="E2">
<type class="Binding" />
<theme idref="A2" />
<theme idref="A3" />
<clue>Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist <clueType>binding</clueType> as revealed by a new monoclonal antibody.</clue>
<comment>NO COREFETHEME FOR A3</comment>
</event>
<event id="E3">
<type class="Correlation" />
<theme idref="A4" />
<theme idref="E1" />
<clue><clueType>Involvement</clueType> <linkTheme>of</linkTheme> the N-terminal region of the human mineralocorticoid receptor hormone-binding domain <linkTheme>in</linkTheme> agonist and antagonist binding as revealed by a new monoclonal antibody.</clue>
<comment>TPS A4</comment>
</event>
<event id="E4">
<type class="Correlation" />
<theme idref="A4" />
<theme idref="E2" />
<clue><clueType>Involvement</clueType> <linkTheme>of</linkTheme> the N-terminal region of the human mineralocorticoid receptor hormone-binding domain <linkTheme>in</linkTheme> agonist and antagonist binding as revealed by a new monoclonal antibody.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">To gain a better understanding of the mechanism of binding to the <term sem="Protein_family_or_group" id="T4" lex="human_mineralocorticoid_receptor">human mineralocorticoid receptor</term> (<term sem="Protein_family_or_group" id="T5" lex="hMR">hMR</term>), we developed a new <term sem="Protein_family_or_group" id="T6" lex="monoclonal_antibody">monoclonal antibody</term> (<term sem="Protein_family_or_group" id="T7" lex="mAb">mAb</term>) raised against the <term sem="Protein_domain_or_region" id="T8" lex="hormone-binding_domain">hormone-binding domain</term> (<term sem="Protein_domain_or_region" id="T9" lex="HBD">HBD</term>).</sentence>
<event id="E5">
<type class="Binding" />
<theme idref="T5" />
<clue>To gain a better understanding of the mechanism of <clueType>binding</clueType> <linkTheme>to</linkTheme> the human mineralocorticoid receptor (hMR), we developed a new monoclonal antibody (mAb) raised against the hormone-binding domain (HBD).</clue>
</event>
<sentence id="S3">For this purpose, <term sem="Multicellular_organism_natural" id="T10" lex="mouse">mice</term> were immunized with a <term sem="Protein_complex" id="T11" lex="fusion_protein">fusion protein</term> including the sequence <term sem="Protein_domain_or_region" id="T12" lex="Thr729-Lys984">Thr729-Lys984</term> of <term sem="Protein_family_or_group" id="T13" lex="hMR">hMR</term>.</sentence>
<sentence id="S4">After <term sem="Other" id="T14" lex="ELISA_screening">ELISA screening</term>, <term sem="Protein_molecule" id="T15" lex="mAb_18C7">mAb 18C7</term> was selected for its specificity towards the <term sem="Protein_domain_or_region" id="T16" lex="HBD">HBD</term>.</sentence>
<sentence id="S5">This antibody recognized both the <term sem="Protein_family_or_group" id="A5">denatured</term> and <term sem="Protein_family_or_group" id="A6">native</term> <term sem="Protein_family_or_group" id="T17" lex="native_MR_form">MR forms</term>, as well as the <term sem="Protein_molecule" id="T18" lex="hetero-oligomeric_MR_form">hetero-oligomeric MR form</term> and the <term sem="Protein_molecule" id="T19" lex="transformed_MR_state">transformed <term sem="Protein_family_or_group" id="A50">MR</term> state</term>.</sentence>
<event id="E7">
<type class="Binding" />
<theme idref="T15" />
<theme idref1="T17" idref="A5" />
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, as well as the hetero-oligomeric MR form and the transformed MR state.</clue>
<comment>NER T17 MOD</comment>
</event>
<event id="E8">
<type class="Binding" />
<theme idref="T15" />
<theme idref1="T17" idref="A6" />
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, as well as the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event id="E9">
<type class="Binding" />
<theme idref="T15" />
<theme idref="T18" />
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, <linkTheme>as well as</linkTheme> the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event id="E10">
<type class="Binding" />
<theme idref="T15" />
<theme idref="T19" />
<clue><corefTheme>This antibody</corefTheme> <clueType>recognized</clueType> both the denatured and native MR forms, <linkTheme>as well as</linkTheme> the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event id="E110">
<type class="Protein_metabolism" />
<theme idref="T17" />
<clue>This antibody recognized both the <clueType>denatured</clueType> and native MR forms, as well as the hetero-oligomeric MR form and the transformed MR state.</clue>
</event>
<event id="E210">
<type class="Protein_metabolism" />
<theme idref="A50" />
<clue>This antibody recognized both the denatured and native MR forms, as well as the hetero-oligomeric MR form and the <clueType>transformed</clueType> MR state.</clue>
</event>
<sentence id="S6">By using several <term sem="Protein_molecule" id="T20" lex="HBD_subfragment">HBD subfragments</term>, the <term sem="Protein_domain_or_region" id="T21" lex="mAb_18C7_epitope"><term sem="Protein_molecule" id="T22" lex="mAb_18C7">mAb 18C7</term> epitope</term> was located in the <term sem="Protein_domain_or_region" id="T23" lex="N-terminal_region">N-terminal region</term> of the <term sem="Protein_domain_or_region" id="T24" lex="HBD">HBD</term> from <term sem="Protein_domain_or_region" id="T25" lex="Thr729_to_Leu765">Thr729 to Leu765</term>.</sentence>
<sentence id="S7">We then studied the effect of the antibody on <term sem="Lipid" id="T26" lex="aldosterone">aldosterone</term> and <term sem="Lipid" id="T27" lex="progesterone">progesterone</term> binding to the <term sem="Protein_family_or_group" id="T28" lex="hMR">hMR</term>.</sentence>
<event id="E12">
<type class="Binding" />
<theme idref="T26" />
<theme idref="T28" />
<clue>We then studied the effect of the antibody on aldosterone and progesterone <clueType>binding</clueType> <linkTheme>to</linkTheme> the hMR.</clue>
</event>
<event id="E13">
<type class="Binding" />
<theme idref="T27" />
<theme idref="T28" />
<clue>We then studied the effect of the antibody on aldosterone and progesterone <clueType>binding</clueType> <linkTheme>to</linkTheme> the hMR.</clue>
</event>
<event uncertainty="doubtful" id="E14">
<type class="Regulation" />
<theme idref="E12" />
<cause idref="T22" />
<clue>We then studied the <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the antibody</corefCause> <linkTheme>on</linkTheme> aldosterone and progesterone binding to the hMR.</clue>
</event>
<event uncertainty="doubtful" id="E15">
<type class="Regulation" />
<theme idref="E13" />
<cause idref="T22" />
<clue>We then studied the <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the antibody</corefCause> <linkTheme>on</linkTheme> aldosterone and progesterone binding to the hMR.</clue>
</event>
<sentence id="S8">When <term sem="Protein_molecule" id="T29" lex="18C7">18C7</term> was incubated with <term sem="Protein_molecule" id="T30" lex="liganded_MR">liganded <term sem="Protein_family_or_group" id="A7">MR</term></term>, it was able to partly displace (20%) the hormone from its binding site.</sentence>
<event id="E16">
<type class="Binding" />
<theme idref="A7" />
<theme idref="T26" />
<clue>When 18C7 was incubated with <clueType>liganded</clueType> MR, it was able to partly displace (20%) the hormone from its binding site.</clue>
</event>
<event id="E17">
<type class="Binding" />
<theme idref="A7" />
<theme idref="T27" />
<clue>When 18C7 was incubated with <clueType>liganded</clueType> MR, it was able to partly displace (20%) the hormone from its binding site.</clue>
</event>
<event id="E18">
<type />
<theme idref="T26" />
<theme idref="T24" />
<clue>When 18C7 was incubated with liganded MR, it was able to partly <clueType>displace</clueType> (20%) <corefTheme idref1="T26">the hormone</corefTheme> <linkTheme>from</linkTheme> <corefTheme idref1="T24">its binding site</corefTheme>.</clue>
<comment>SOO</comment>
</event>
<event id="E19">
<type />
<theme idref="T27" />
<theme idref="T24" />
<clue>When 18C7 was incubated with liganded MR, it was able to partly <clueType>displace</clueType> (20%) <corefTheme idref1="T27">the hormone</corefTheme> <linkTheme>from</linkTheme> <corefTheme idref1="T24">its binding site</corefTheme>.</clue>
<comment>SOO</comment>
</event>
<event id="E20">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="T29" />
<clue>When 18C7 was incubated with liganded MR, <corefCause>it</corefCause> was able to partly displace (20%) the hormone from its binding site.</clue>
</event>
<event id="E21">
<type class="Positive_regulation" />
<theme idref="E19" />
<cause idref="T29" />
<clue>When 18C7 was incubated with liganded MR, <corefCause>it</corefCause> was able to partly displace (20%) the hormone from its binding site.</clue>
</event>
<sentence id="S9">When <term sem="Protein_molecule" id="T31" lex="18C7">18C7</term> was incubated with <term sem="Protein_molecule" id="T32" lex="MR">MR</term> before <term sem="Lipid" id="T33" lex="aldosterone">aldosterone</term> or <term sem="Lipid" id="T34" lex="progesterone">progesterone</term>, the antibody inhibited 75-80% of the binding.</sentence>
<event id="E22">
<type class="Binding" />
<theme idref="T33" />
<theme idref="T32" />
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of <corefTheme>the</corefTheme> <clueType>binding</clueType>.</clue>
</event>
<event id="E23">
<type class="Binding" />
<theme idref="T34" />
<theme idref="T32" />
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of <corefTheme>the</corefTheme> <clueType>binding</clueType>.</clue>
</event>
<event id="E24">
<type class="Negative_regulation" />
<theme idref="E22" />
<cause idref="T31" />
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, <corefCause>the antibody</corefCause> <clueType>inhibited</clueType> 75-80% of the binding.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E23" />
<cause idref="T31" />
<clue>When 18C7 was incubated with MR before aldosterone or progesterone, <corefCause>the antibody</corefCause> <clueType>inhibited</clueType> 75-80% of the binding.</clue>
</event>
<sentence id="S10">The effect of <term sem="Protein_molecule" id="T35" lex="18C7">18C7</term> on the binding was similar with both hormones.</sentence>
<event id="E26">
<type class="Binding" />
<theme idref="T33" />
<theme idref="T32" />
<clue>The effect of 18C7 on the <clueType>binding</clueType> was similar with <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTEHEME FOR T32</comment>
</event>
<event id="E27">
<type class="Binding" />
<theme idref="T34" />
<theme idref="T32" />
<clue>The effect of 18C7 on the <clueType>binding</clueType> was similar with <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTEHEME FOR T32</comment>
</event>
<event id="E28">
<type class="Regulation" />
<theme idref="E26" />
<cause idref="T35" />
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> 18C7 <linkTheme>on</linkTheme> the binding was similar with both hormones.</clue>
</event>
<event id="E29">
<type class="Regulation" />
<theme idref="E27" />
<cause idref="T35" />
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> 18C7 <linkTheme>on</linkTheme> the binding was similar with both hormones.</clue>
</event>
<sentence id="S11">A sucrose gradient analysis indicated the simultaneous presence of two kinds of receptor complexes: the <term sem="Protein_complex" id="T36" lex="steroid-MR_complex"><term sem="Organic_compound_other" id="A8">steroid</term>-<term sem="Protein_family_or_group" id="A9">MR</term> complex</term> and the <term sem="Protein_complex" id="T37" lex="antibody-MR_complex"><term sem="Protein_family_or_group" id="A10">antibody</term>-<term sem="Protein_family_or_group" id="A11">MR</term> complex</term>.</sentence>
<event id="E30">
<type class="Binding" />
<theme idref="A8" />
<theme idref="A9" />
<clue><clueExperiment>A sucrose gradient analysis</clueExperiment> indicated the simultaneous <clueType>presence</clueType> <linkTheme>of</linkTheme> <corefTheme>two kinds of receptor complexes</corefTheme>: the steroid-MR <clueType>complex</clueType> and the antibody-MR complex.</clue>
</event>
<event id="E31">
<type class="Binding" />
<theme idref="A10" />
<theme idref="A11" />
<clue><clueExperiment>A sucrose gradient analysis</clueExperiment> indicated the simultaneous <clueType>presence</clueType> <linkTheme>of</linkTheme> <corefTheme>two kinds of receptor complexes</corefTheme>: the steroid-MR complex and the antibody-MR <clueType>complex</clueType>.</clue>
</event>
<sentence id="S12">After its associated proteins, especially the <term sem="Protein_molecule" id="T38" lex="heat-shock_protein_hsp90">heat-shock protein hsp90</term>, had been cross-linked with the <term sem="Protein_family_or_group" id="T39" lex="hMR">hMR</term> by <term sem="Organic_compound_other" id="T40" lex="dimethylpimelimidate">dimethylpimelimidate</term>, <term sem="Protein_molecule" id="T41" lex="18C7">18C7</term> was still able to react with the receptor.</sentence>
<event id="E32">
<type class="Binding" />
<theme idref="T38" />
<theme idref="T39" />
<theme idref="T40" />
<clue>After its associated proteins, especially the heat-shock protein hsp90, had been <clueType>cross-linked</clueType> <linkTheme>with</linkTheme> the hMR <linkTheme>by</linkTheme> dimethylpimelimidate, 18C7 was still able to react with the receptor.</clue>
</event>
<event id="E33">
<type class="Regulation" />
<theme idref="T39" />
<cause idref="T41" />
<clue>After its associated proteins, especially the heat-shock protein hsp90, had been cross-linked with the hMR by dimethylpimelimidate, 18C7 was still able to <clueType>react</clueType> <linkTheme>with</linkTheme> <corefTheme>the receptor</corefTheme>.</clue>
</event>
<event assertion="non-exist" id="E34">
<type class="Negative_regulation" />
<theme idref="E33" />
<cause idref="E32" />
<clue><linkCause>After</linkCause> its associated proteins, especially the heat-shock protein hsp90, had been cross-linked with the hMR by dimethylpimelimidate, 18C7 was <clueType>still able to</clueType> react with the receptor.</clue>
</event>
<sentence id="S13">Our results indicated that the <term sem="Protein_domain_or_region" id="T42" lex="epitope">epitope</term> recognized by <term sem="Protein_molecule" id="T43" lex="18C7">18C7</term> was directly implicated in hormone binding.</sentence>
<event id="E35">
<type class="Binding" />
<theme idref="T42" />
<theme idref="T43" />
<clue>Our results indicated that the epitope <clueType>recognized</clueType> <linkTheme>by</linkTheme> 18C7 was directly implicated in hormone binding.</clue>
</event>
<event id="E36">
<type class="Binding" />
<theme idref="T32" />
<theme idref="T33" />
<clue>Our results indicated that the epitope recognized by 18C7 was directly implicated in <corefTheme>hormone</corefTheme> <clueType>binding</clueType>.</clue>
<comment>NO COREFTEHEME FOR T32</comment>
</event>
<event id="E37">
<type class="Binding" />
<theme idref="T32" />
<theme idref="T34" />
<clue>Our results indicated that the epitope recognized by 18C7 was directly implicated in <corefTheme>hormone</corefTheme> <clueType>binding</clueType>.</clue>
<comment>NO COREFTEHEME FOR T32</comment>
</event>
<event id="E38">
<type class="Correlation" />
<theme idref="T42" />
<theme idref="E36" />
<clue>Our results indicated that the epitope recognized by 18C7 was directly <clueType>implicated</clueType> <linkTheme>in</linkTheme> hormone binding.</clue>
</event>
<event id="E39">
<type class="Correlation" />
<theme idref="T42" />
<theme idref="E37" />
<clue>Our results indicated that the epitope recognized by 18C7 was directly <clueType>implicated</clueType> <linkTheme>in</linkTheme> hormone binding.</clue>
</event>
<sentence id="S14">The lack of <term sem="Organic_compound_other" id="A13">steroid</term> binding of <term sem="Protein_molecule" id="A12"><term sem="Protein_domain_or_region" id="T44" lex="HBD">HBD</term> mutants with the <term sem="Protein_domain_or_region" id="T45" lex="Thr729-Leu765_sequence">Thr729-Leu765 sequence</term> deleted</term> [Jalaguier, Mesnier, Leger and Auzou (1996) J.Steroid Biochem.Mol.Biol.57, 43-50] supports this hypothesis.</sentence>
<event assertion="non-exist" id="E40">
<type class="Binding" />
<theme idref="A13" />
<theme idref="A12" />
<clue>The lack of steroid <clueType>binding</clueType> <linkTheme>of</linkTheme> HBD mutants with the Thr729-Leu765 sequence deleted [Jalaguier, Mesnier, Leger and Auzou (1996) J.Steroid Biochem.Mol.Biol.57, 43-50] supports this hypothesis.</clue>
<comment>TPS A12</comment>
</event>
<sentence id="S15">Because of the similar behaviours of <term sem="Lipid" id="T46" lex="aldosterone">aldosterone</term> and <term sem="Lipid" id="T47" lex="progesterone">progesterone</term>, we conclude that the <term sem="Protein_molecule" id="A14"><term sem="Protein_domain_or_region" id="T48" lex="N-terminal_Thr729-Leu765_region">N-terminal Thr729-Leu765 region</term> of the <term sem="Protein_domain_or_region" id="T49" lex="HBD">HBD</term></term> is similarly involved in the binding of both hormones.</sentence>
<event id="E41">
<type class="Binding" />
<theme idref="T33" />
<theme idref="T32" />
<clue>Because of the similar behaviours of aldosterone and progesterone, we conclude that the N-terminal Thr729-Leu765 region of the HBD is similarly involved in the <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTHEME FOR T32, TPS A14</comment>
</event>
<event id="E42">
<type class="Binding" />
<theme idref="T34" />
<theme idref="T32" />
<clue>Because of the similar behaviours of aldosterone and progesterone, we conclude that the N-terminal Thr729-Leu765 region of the HBD is similarly involved in the <clueType>binding</clueType> <linkTheme>of</linkTheme> <corefTheme>both hormones</corefTheme>.</clue>
<comment>NO COREFTHEME FOR T32</comment>
</event>
<event id="E43">
<type class="Correlation" />
<theme idref="A14" />
<theme idref="E41" />
<clue>Because of the similar behaviours of aldosterone and progesterone, we conclude that the N-terminal Thr729-Leu765 region of the HBD is similarly <clueType>involved</clueType> <linkTheme>in</linkTheme> the binding of both hormones.</clue>
</event>
<event id="E44">
<type class="Correlation" />
<theme idref="A14" />
<theme idref="E42" />
<clue>Because of the similar behaviours of aldosterone and progesterone, we conclude that the N-terminal Thr729-Leu765 region of the HBD is similarly <clueType>involved</clueType> <linkTheme>in</linkTheme> the binding of both hormones.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
